1.
de Portu S, Carteni G, Belisari A. Economic evaluation of temsirolimus on the basis of the results of the ARCC (Advanced Renal-Cell Carcinoma) study. Farmeconomia. Health Economics and Therapeutic Pathways. 2009;10(2):93-97. https://doi.org/10.7175/fe.v10i2.167